Aspira Pathlab & Diagnostics Balance Sheet Health
Financial Health criteria checks 6/6
Aspira Pathlab & Diagnostics has a total shareholder equity of ₹101.4M and total debt of ₹27.8M, which brings its debt-to-equity ratio to 27.4%. Its total assets and total liabilities are ₹147.1M and ₹45.7M respectively.
Key information
27.4%
Debt to equity ratio
₹27.82m
Debt
| Interest coverage ratio | n/a |
| Cash | ₹13.84m |
| Equity | ₹101.43m |
| Total liabilities | ₹45.66m |
| Total assets | ₹147.10m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 540788's short term assets (₹43.6M) exceed its short term liabilities (₹20.7M).
Long Term Liabilities: 540788's short term assets (₹43.6M) exceed its long term liabilities (₹25.0M).
Debt to Equity History and Analysis
Debt Level: 540788's net debt to equity ratio (13.8%) is considered satisfactory.
Reducing Debt: 540788's debt to equity ratio has reduced from 130% to 27.4% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable 540788 has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: 540788 is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 34% per year.